Healthcare · Operations & Throughput
How to Automate Document Processing in Medical Devices (Step-by-Step)
medical device manufacturers, field service leaders, quality teams, and commercial operations usually arrive here with two questions: what does AI-native document processing actually ship, and what does it cost. Both are answered below, alongside the operating posture and the governance frame.
Projects from $15k · Refundable 7 days · Kickoff within 5 days
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native document processing for medical devices — Production document processing for medical devices delivered in vertical slices, each gated by the labelled test set captured during Discovery, each handing operational ownership progressively to your team. Expected delta on documents per hour: −75%.
Key facts
- Industry
- Medical Devices
- Use case
- Document Processing
- Intent cluster
- Operations & Throughput
- Primary KPI
- documents per hour, extraction accuracy, exception rate, and processing cost
- Top benchmark
- Time-to-onboard new operator: 8 weeks → 2 weeks (−75%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 3 weeks → Build 8 weeks → Run continuous (regulated industry)
- Team size
- 2 senior delivery + 1 part-time reviewer trainer
- Discovery price
- $6k · 2-week sprint
- Build price
- $20k–$28k · 6-10 weeks
Primary outcome
extract meaning from documents at scale
What we ship
document intake pipeline, extraction schema, validation workflow, and exception queue
KPIs we report on
documents per hour, extraction accuracy, exception rate, and processing cost
Why Medical Devices teams hire us for this
Medical Devices buyers we talk to share a common frustration: too many AI vendor demos, too few production deployments that survive a quarterly review. AI-native document processing is the answer to that gap — every engagement we ship is designed to pass a CFO's challenge, a risk officer's review, and an operator's daily use, simultaneously.
Operations benchmarks across medical devices typically show 20-35% of operator time absorbed by status checks, handoffs, and exception triage. AI-native automation reclaims that block first because it has the highest volume and lowest decision risk.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of document processing in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Time-to-onboard new operator AI assistant handles the long tail of edge cases that previously required senior coaching | 8 weeks | 2 weeks | −75% |
Cycle time per transaction Measured on labelled production samples; excludes outliers >2σ | 47 min median | 8 min median | −83% |
Error rate on repeatable steps Quality control sampling; AI-native gates catch errors before downstream propagation | 6.1% | 1.4% | −77% |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
The architectural choice that defines the operating model for document processing in medical devices is not the model — it is the case representation. A case is the atomic unit of work the system processes: a ticket, a record, a claim, a request, a transaction. We design the case shape during Discovery, instrument every state transition during Build, and operate the workflow against that case-level telemetry during Run. Case-level telemetry is what makes the workflow legible to medical devices leadership; it is also what lets us detect drift early.
What we build inside the workflow
A strong implementation starts with a clear inventory of the current work. For Medical Devices, that means understanding how data moves through QMS, CRM, field service platforms, LMS, regulatory document systems, who owns each decision, and where handoffs slow the team down. We document current cycle time, error rates, quality review steps, rework, and the volume of requests or records flowing through the process. The automation layer will reads files, extracts fields, compares clauses or values, identifies gaps, and prepares structured outputs.
Reference architecture
4-layer AI-native workflow for operations & throughput
Intake → context → action → review. The loop is closed: every reviewer decision feeds the next iteration of the prompt and the retrieval index. Without the closed loop, accuracy degrades silently over months.See the full architecture diagram for Operations & Throughput →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the alternatives for document processing in medical devices: in-house build, BPO retainer, generic SaaS subscription, traditional consulting engagement.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | Two quarters minimum | Production traffic within 6-10 weeks |
| Pricing model | FTE hourly retainer or fixed staffing | Three independent commercial envelopes |
| Audit / governance | Document-driven, periodic snapshot | Runtime guardrails + audit log + governance map + quarterly attestation |
| Operator throughput lift | 1.0× (baseline) | −83% |
| Cost per unit | Linear with operator headcount | Typically 60-80% lower |
| End-of-engagement | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Operations engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$6k
2-week sprint
Phase 2 · Build
$20k–$28k
6-10 weeks
Phase 3 · Run
$2.5k–$4k / mo
optional, hourly bank also available
~$32k–$58k typical year 1 (60% take the run option for ~6 months)
Workflow redesign, system integration, governance, and weekly operating cadence during Run.
Two-week Discovery, then your decision. Build is fixed-price against the Discovery output. Run, if you opt in, is month-to-month with a documented exit path.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We sit with the operator team running the workflow today, watch a working day end-to-end, and produce the baseline that Build will be measured against. Two-week sprint, fixed price.
Phase 2 · Weeks 2–4
Design
Design phase is where the irreversible architectural choices are made: layer boundaries, substitution interfaces, governance posture, evaluation methodology. We invest disproportionately here because corrections in Build are 10× more expensive.
Phase 3 · Weeks 4–8
Build
Vertical-slice delivery against the labelled test set. Each slice ships to production, gated by eval criteria. By end of Build, the workflow is operating on real traffic with the calibration discipline established.
Phase 4 · Weeks 8+
Run
Monthly month-to-month Run cadence: Monday metric review, Wednesday prompt and retrieval refresh, Friday calibration audit. The cadence is the deliverable; the prompts are the artefacts that change between cadence cycles.
Interactive ROI calculator
Estimate your AI-native ROI for document processing
Reference inputs below are typical for medical devices teams in the operations cluster. Adjust them to match your situation.
Projected
Current monthly cost
$56,000
AI-native monthly cost
$18,520
Annual savings
$449,760
67% cost reduction · ~2,601 operator-hours freed / month
Governance and risk controls
Governance fails in two predictable ways in medical devices: paper controls that nobody enforces at runtime, and runtime controls that nobody can document for auditors. We build for both audiences. Every guardrail is enforced in code, and every guardrail is documented in the governance map with the line of code that implements it. The map and the code are kept in sync as part of the Run cadence.
How we report ROI
The ROI calculation we refuse to fudge on document processing is the time-to-value curve. Most medical devices AI projects report ROI on cherry-picked metrics at quarter-end. We report against a baseline captured in Discovery, on a fixed metric defined before Build, with the methodology documented in the Statement of Work. Boring, defensible, repeatable.
Selected portfolio
Real builds — document processing in medical devices and adjacent sectors
Below are engagements drawn from our active portfolio where the workflow rhymed with document processing in medical devices or in adjacent contexts. Scope and stack are accurate; client identities are withheld under engagement NDAs.
Q3 2025
Radiology workflow application — case handling and reporting
Medical imaging operator · Europe
Application supporting radiology workflow: case intake, structured reporting, document handling, and quality-assurance loop. Designed for regulated medical-imaging context with audit trail and role-based access.
- Web app + secure storage
- Structured reporting
- Audit-trail compliance
Q2 2026
Internal staff portal — multi-association operations in role-based dashboards
Mid-market property operator · GCC region
Role-scoped portal for property managers, accountants, and maintenance staff. Reuses the OA data model from the management SaaS (zero duplication), adds multi-association switching, maintenance ticket lifecycle, financial reporting, and document storage tied to each association workspace.
- Next.js + tRPC
- NextAuth role-based access
- Drizzle ORM shared schema
Q1 → Q2 2026
National legal marketplace — directory, bookings, legal tools, emergency contacts
Government-licensed legal services platform · GCC region
Ministry-licensed bilingual EN/AR platform: directory of certified lawyers, firms, mediators and arbitrators; multi-channel appointment booking (video, phone, in-office); free legal tools (court fees, deadlines, legal interest); police directory with map + hotlines; provider verification workspace; PDF document generation with QR-coded provenance.
- Next.js 16 monorepo (Turborepo)
- Bilingual EN/AR (next-intl)
- Postmark + Web Push
Client identities withheld under engagement NDAs. Sector, geography, and scope are accurate. Full case studies on request.
Common pitfall & mitigation
The failure mode we see most often on AI-native document processing engagements in medical devices contexts.
Operator distrust
Senior operators reject AI suggestions silently, throughput stagnates
Co-design with 2-3 senior operators during Build; their feedback shapes confidence thresholds
How the regulatory frame shapes the architecture
For medical devices teams, regulatory exposure on document processing typically clusters around four failure modes: customer harm from an incorrect automated decision, supervisory finding from inadequate documentation, internal audit gap from missing controls, and reputational damage from a poorly-explained system. Each failure mode has a distinct mitigation, and we wire all four into the Build phase rather than treating any of them as Run-phase patches.
Customer-harm mitigation begins with a confidence threshold calibrated against the labelled test set captured in Discovery. Anything below the threshold routes to a reviewer with the supporting evidence pre-assembled; the reviewer's decision feeds back into the calibration loop. Supervisory-finding mitigation is the audit log architecture — immutable, queryable, exportable — coupled with quarterly attestation packs that mirror the templates the supervisor uses in examinations of medical devices firms. Audit-gap mitigation is the named-owner map: every control has a person, every person has a documented responsibility, and the map is on the same dashboard as the metrics. Reputational mitigation is the explainability layer — every decision the system communicates externally carries the supporting evidence so the recipient (and any downstream party) can interrogate it.
The combined posture is not "AI inside a compliance wrapper" — it is a workflow built for the regulated reality of medical devices from week one. We have shipped this pattern across enough engagements to know which controls compress under scale, which controls drift over time, and which controls audit teams actually inspect. The Build statement of work names them all, the Run cadence keeps them current, and the dashboard makes them legible to anyone who needs to see them — operator, compliance, audit, regulator, board.
Third-party risk management for AI components in medical devices is a growing concern that most workflows handle poorly. document processing engagements typically depend on a model provider, a retrieval store, a vector database, sometimes a fine-tuning service. Each is a vendor in your risk register. We map them all during Build, document substitution paths for each, and demonstrate substitutability in the eval harness — so when one vendor changes pricing, terms, or availability, the workflow can move without a re-architecture.
Medical Devices regulatory expectations on AI have hardened over the last twenty-four months. Supervisors who would once accept "we use AI in this workflow" as a sufficient disclosure now ask for the model card, the validation evidence, the override path, and the customer-disclosure language. Vendors who built for the looser bar are scrambling. We built for the harder bar from the start, because the engagement model we sell medical devices teams is one we can defend in front of any reasonable supervisor.
For document processing, that defense rests on five artefacts the Build phase produces. The model card documents the deployed system: what it does, what it does not do, the training data lineage, the evaluation methodology, the known failure modes. The validation evidence is the labelled test set with its full provenance, the periodic eval reports, and the calibration curves. The override path is documented in the operator playbook and instrumented in the reviewer UI. The customer-disclosure language is drafted with your legal team during Build and tested with sample interactions before launch. The control map ties each control to a named owner and a measurable SLA.
The artefacts live in version control alongside the code, not in a shared drive. They are reviewed quarterly during Run and updated when the system changes. When a supervisor asks for them, the export is a single command. This is not theatre — it is the operating posture that lets your team say "yes, we use AI in this workflow, and here is the evidence we run it responsibly", with the evidence available in the time it takes to brew coffee.
The concrete first-30-day delivery plan
Our Build cadence on document processing for medical devices is bias-corrected against the two failure modes we have seen kill medical devices AI projects most often: scoping that drifts week-by-week, and a labelled test set that arrives in week 6 instead of week 1.
We fix the scoping by signing the Build statement of work before any code is written — the deliverables are named, the integration footprint is bounded, the milestones have dates. We fix the labelled test set timing by treating it as the week-1 deliverable. Week 1 is not "scoping week" — it is "labelled-test-set week", because every subsequent engineering decision is measured against that test set.
Week 2: retrieval index live with first batch of approved sources. Week 3: intake classifier scoring against the test set, first calibration report. Week 4: action layer drafting with reviewer approval; first end-to-end case flow. Week 5-6: thin slice in production on 5-15% of routine medical devices traffic, first weekly review with the operator team. Weeks 7-10: production envelope widens case-class by case-class, calibration loop tunes against the empirical evidence, exceptional cases route to enriched escalation. By day 60-70, the workflow is operating at its target envelope.
Most medical devices AI projects fail in the first month for the same reason: too much time in scoping, too little in shipping. Our Build phase inverts that ratio deliberately. Week 1 has running code; week 4 has reviewable thin-slice production traffic; week 6 has a defensible accuracy baseline against the labelled test set.
The shape of the first week is opinionated. By end of day Wednesday, the retrieval index is loaded with the first batch of approved sources. By end of day Friday, the intake classifier is hitting the labelled test set with an initial accuracy number. The number is intentionally not impressive — it is a baseline against which weeks 2 and 3 measure progress. Most teams underestimate how motivating that early concrete number is for both the operator team (it stops feeling abstract) and the engineering team (the eval feedback loop is closing).
From week 2 onward the cadence is metric-driven. Every Friday produces a delta report against the labelled test set: which slices improved, which regressed, what the next iteration targets. The operator team participates in the Friday review; their judgment on edge cases becomes the next iteration's prompt or retrieval tweak. By week 6, the system has been through 12-15 evaluation cycles, each with medical devices-specific calibration, each tied to a documented change. The workflow that hits production at the end of Build is the workflow that has survived a month of empirical correction, not the workflow that looked good in the architecture diagram.
Closest precedent in our portfolio
The engagement that most closely rhymes with document processing in medical devices is summarised below. Identity withheld under engagement NDA; sector and stack are accurate.
Radiology workflow application — case handling and reporting. Application supporting radiology workflow: case intake, structured reporting, document handling, and quality-assurance loop. Designed for regulated medical-imaging context with audit trail and role-based access. (Medical imaging operator · Europe, Q3 2025.)
The architectural choices that worked there translate to medical devices document processing with two adjustments: the data-source mix shifts to match your operating systems (QMS, CRM, and adjacent), and the reviewer SLAs adjust to your team's operating cadence. The four-layer pattern (intake, context, action, review), the evaluation discipline, and the audit posture are portable.
For US buyers
US compliance scaffolding for document processing in medical devices (FDA 21 CFR Part 11, HIPAA, NIST AI RMF)
Medical Devices engagements touching US clients on document processing ship with the regulatory scaffolding your procurement, compliance, and legal teams expect. The framework that matters most for medical devices is Electronic Records and Electronic Signatures (FDA 21 CFR Part 11) — addressed below alongside the adjacent frames we encounter.
FDA 21 CFR Part 11
Electronic Records and Electronic Signatures
Authority: U.S. Food and Drug Administration
- Scope
- Validation of electronic records in GxP environments, audit trails, electronic signatures, system access controls.
- How we ship inside it
- Pharma and medical-device engagements include 21 CFR Part 11 system validation documentation: design qualification (DQ), installation qualification (IQ), operational qualification (OQ), performance qualification (PQ). Audit trails are tamper-evident and signature-bound.
HIPAA
Health Insurance Portability and Accountability Act
Authority: U.S. Department of Health and Human Services / OCR
- Scope
- Protected Health Information (PHI) handling, security safeguards, breach notification, business associate accountability.
- How we ship inside it
- We sign a Business Associate Agreement (BAA) on healthcare engagements that touch PHI. The architecture supports BAA-covered model providers (Anthropic BAA, Azure OpenAI BAA, AWS Bedrock BAA). Audit log retention defaults to 6 years (HIPAA minimum). PHI handling follows minimum-necessary principle at the prompt and retrieval layers.
NIST AI RMF
NIST AI Risk Management Framework (AI 100-1)
Authority: U.S. National Institute of Standards and Technology
- Scope
- Voluntary framework: Govern, Map, Measure, Manage functions for AI system risk.
- How we ship inside it
- Every engagement maps to NIST AI RMF during Discovery. The control map produced becomes the artefact your internal audit and security teams use to defend the workflow.
For US companies
Start a US-friendly engagement
Discovery from $8,500–$12,000, Build from $35,000–$75,000, optional Run from $5k/mo. Fixed-price, milestone-billed, you own every artefact. Send a short brief and we reply within 5 business days. 11am–4pm ET overlap for live syncs.
USD pricing
Discovery $8,500–$12,000 · Build $35,000–$75,000
US-style commercial
MSA / SOW / mutual NDA standard. DPA with SCCs included.
Limited capacity
We onboard 3–5 new clients per quarter to protect delivery quality.
Build internally or work with us
The opportunity cost of building first in medical devices is often invisible: 6-9 months spent hiring, tooling, and converging on a reference architecture is 6-9 months of competitors shipping. The engagement model we propose front-loads the reference architecture and the senior delivery team, then transitions the operation to your team once the pattern is proven.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move documents per hour, extraction accuracy, exception rate, and processing cost within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
If you can pick only one wedge, pick the document processing subflow that is currently absorbing the most senior-operator time on cases that are mostly routine but require context the system does not surface today. That subflow has the highest immediate ROI and the cleanest path to a labelled test set. We have shipped this pattern across enough medical devices engagements to know which subflows compound and which stall. The Discovery sprint identifies the wedge concretely. The Build phase ships it as a thin slice within 6-8 weeks. The Run phase compounds value as the labelled test set grows, the prompt library tunes to your category, and the reviewer team calibrates against real traffic. The 90-day milestone is a defensible empirical track record on which to scope the next engagement.
Frequently asked questions
How do you automate document processing in medical devices with AI?+
Three phases. Discovery (2 weeks) produces the labelled test set, the system map, and the Build statement of work. Build (6-10 weeks) ships a thin-slice production deployment on top of QMS and adjacent systems, with versioned prompts and a reviewer queue. Run (optional, month-to-month) operates the workflow weekly against documents per hour, extraction accuracy, exception rate, and processing cost.
What does it cost to automate document processing for medical devices teams?+
Three phases, billed separately. Discovery sprint: $6k (2-week sprint). Build engagement: $20k–$28k (6-10 weeks). Run retainer: $2.5k–$4k / mo (optional, hourly bank also available). ~$32k–$58k typical year 1 (60% take the run option for ~6 months). Workflow redesign, system integration, governance, and weekly operating cadence during Run.
What is the best AI agent for document processing in medical devices?+
There is no single "best" off-the-shelf agent for document processing in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI document processing for medical devices?+
End-to-end lead time from kickoff to thin-slice production: 6-10 weeks. End-to-end to full operating envelope: 10-14 weeks. documents per hour, extraction accuracy, exception rate, and processing cost is instrumented from day one of Build; the dashboard goes live by week 4-5; production traffic starts by week 6-8. By 90 days, leadership has a 30-60 day record of operating performance against the Discovery baseline.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
What does Build look like week by week?+
Week 1-2: discovery output, labelled test set, integration plan. Week 3-4: retrieval index live, intake classifier scoring against the test set. Week 5-6: action layer with reviewer approval, thin-slice production traffic. Week 7-10: production envelope widens, calibration tunes against empirical evidence. By end of Build, document processing is operating at its target envelope with the calibration discipline in place.
Do you train models on our data?+
No. We do not train any model on client data. Anthropic Zero-Data-Retention is enabled by default; OpenAI default-no-training is honoured. Prompts, retrieval indexes, audit logs, and integration data live in your cloud account under your IAM. At engagement end, every artefact transfers to your repository.
What if we want to exit the engagement?+
Discovery and Build are fixed-scope, so there is no mid-engagement exit cost. Run is month-to-month with 30-day notice. Every artefact (prompts, eval harness, integration code, dashboards, runbooks) is in your repository throughout the engagement, not behind our SaaS. There is no lock-in.
What does success look like 90 days after Build closes?+
documents per hour, extraction accuracy, exception rate, and processing cost measurably improved against the Discovery baseline. Your team is operating the workflow with the cadence we shipped during Build. The audit log is queryable. The reviewer queue is calibrated. The next workflow scope is informed by real production evidence rather than initial assumptions.
What support is included after the engagement ends?+
Optional Run retainer covers weekly cadence, prompt refresh, retrieval index updates, and reviewer-queue calibration. Architecture-level questions and breaking-change support are billed hourly outside of Run. Most engagements transition Run in-house at month 6-12; we stay available for architecture decisions for 12 months at no extra charge.
How does this integrate with QMS and our existing stack?+
Discovery scopes the integration footprint explicitly. We integrate at the API layer; no replatforming required. The Build statement of work names exactly which systems are connected, which data flows are bidirectional, and what authentication patterns we use (SSO, service accounts, OAuth scopes). The integration code lives in your repository.
What does your team look like during an engagement?+
Discovery: 1 senior delivery lead + 1 PM, ~30 hours/week. Build: 1 senior delivery lead + 2-3 senior AI engineers, ~50-80 hours/week across the team. Run: 1 delivery owner + 1 engineer on weekly cadence. We do not use offshore staff augmentation. Every engineer touching your engagement is senior-level.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Hype Cycle for Artificial Intelligence — Gartner
- MIT Sloan Management Review — AI & Business Strategy — MIT Sloan
- Future of Work: Operations — Deloitte Insights
- Lighthouse Network — Operations AI Adoption — World Economic Forum + McKinsey
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Concepts on this page:
AI workflow·Thin slice·Reviewer queue·Evaluation harness·Tool use·Audit logFull glossary →High-intent reads
Start the engagement
Start a Medical Devices engagement
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.